Melatonin 3mg.

The gap this formula speaks to.

Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.

Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.

Every one of these is a fact the engine could ground.

Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.

• Studied in people18 human studies on Melatonin back this formula, each one cited.
• A mechanism that is settledHow Melatonin works is settled pharmacology.
• Recent work on the recordThe most recent study on this record was published in 2023.
• Serving amount inside the studied rangeEach serving carries 3 mg of Melatonin, inside the range the published research used.
• A stated daily maintenance amountMelatonin is here at a daily maintenance amount, which is what a daily supplement is for.
• Why this formatIt is a tablet, so the amount per serving is fixed and it stores well.
• The exact form, describedThe form on the label is Immediate-release melatonin. The record says what that form is and what it suits.
• Full label disclosureEvery ingredient on this label carries its own declared amount.
• Where it comes from and how it is madeMelatonin is made by synthetic.
• Positions this formula already qualifies forThis formula already qualifies for positions beyond the one it is sold into, on the evidence it carries.
• A position nobody is holding yetSome of those positions are ones almost nobody is selling to yet.

The size of the effect, in plain numbers.

Where a trial measured an actual number, we show it next to the claim. It is the average across the trials, never a promise about one person.

What the trials show about timing.

Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.

• Melatoninwithin about 40 minutes of a single doseMeasured within a day

  In a crossover pharmacokinetic study, 12 healthy male volunteers received 10 mg of oral melatonin and 10 mg intravenously on separate days. Oral melatonin reached mean peak plasma concentration 40.8 minutes after ingestion, with a mean elimination half-life of 53.7 minutes and absolute bioavailability of about 3 percent. A separate randomised double-blind crossover trial in 18 healthy adults aged 18 to 65 measured time to peak concentration of 0.6 hours for 4 mg immediate-release melatonin and 1.56 hours for a 4 mg extended-release form. Both studies measured blood concentration, not sleep. The second was run by employees of Pharmavite, a supplement manufacturer.

  Andersen et al., 2016 (BMC Pharmacol Toxicol)PMID 26893170

  Mun 2023, extended-release versus immediate-release melatonin pharmacokineticsPMID 37150895

  Promising

Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.

How each ingredient usually behaves over time.

One ingredient, from its own page.

• MelatoninAbout 30 to 60 minutes

  Drowsiness usually arrives 30 to 60 minutes after a dose. The body-clock shift builds over a few nights of taking it at the same hour.

  Its own page, the plain answer on timing ↗

How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.

Tablet

It is a tablet, so the amount per serving is fixed and it stores well.